You are here

Taiho Pharmaceutical

Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories

CP Wire

Fri, 07/13/18 - 11:55 am

Arcus Biosciences

Taiho Pharmaceutical

Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories

Fri, 07/13/18 - 09:29 am

Arcus Biosciences

Taiho Pharmaceutical

Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer

CP Wire

Thu, 06/21/18 - 10:13 am

Taiho Pharmaceutical

Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer

Thu, 06/21/18 - 09:53 am

Taiho Pharmaceutical

Taiho Pharmaceutical Announces Termination of Phase III Clinical Trial of the Angiogenesis Inhibitor TSU-68 (orantinib) in Patients with Hepatocellular Carcinoma

Pipeline Review

Sat, 08/2/14 - 10:48 am

Taiho Pharmaceutical

hepatocellular carcinoma